Thalidomide-Induced Hemorrhagic Rash in a Patient With Myelofibrosis and Delta-Granule Storage Pool Disease

Authors :: Roland T. Skeel
Asma Taj
Kamal Kant Singh Abbi
Source :: American Journal of Therapeutics. 22:e6-e7
Publication Year :: 2015
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2015.
Abstract: Thalidomide is one of the immunomodulating agents used in current oncology practice. We present a case of hemorrhagic rash induced by thalidomide in a patient with delta granule storage pool disease. The patient was getting thalidomide for underlying myelofibrosis.

Full Text Access

Tools